admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Mindset Pharma and PharmAla Complete First Sale of Pharmaceutical Grade Psilocybin...

Psychedelic Bulletin #132: COMPASS Pathways Amends Phase 3 Program; Stamets Stack...

Webinar – Unraveling the Top 3 Psychedelic Neuroscience Myths

Webinar – A Somatic Perspective on Sex & Psychedelics: Focusing on...

Psychedelics Weekly – Cannadelic, Concussions, Vital, and More PT News

How To Get Your Start as a Psychedelic Informed Practitioner

PT395 – Thank You Life: Accessibility, Fair Compensation, and Trusting Intuition

COMPASS Pathways to participate in upcoming Cowen 43rd Annual Health Care...

GH Research Reports Full Year 2022 Financial Results and Provides Business...

Algernon NeuroScience Appoints Global TBI Expert and Former NFL Neurological Player...

1...818283...218 Page 82 of 218

EDITOR PICKS

Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin